NASDAQ
Pardes Biosciences, Inc. (PRDS) has a current ratio of 9.81x as of Monday, May 25, 2026. This represents a 36.54% decrease compared to its 12-month average of 15.46x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.